CXCL8 and osteoarthritis: Recently, increasing studies have uncovered that in diabetic patients with osteoarthritis, diabetic treatment such as DPP-4 could partially improve osteoarthritis symptoms by decreasing the production of inflammatory cytokines such as IL-6, IL-8, and TNF-α (86, 87).